Literature DB >> 7272149

Effect of neostigmine and pyridostigmine on the plasma cholinesterase activity.

A Baraka, N Wakid, R Mansour, W Haddad.   

Abstract

The effect of neostigmine 0.05 mg kg-1 or pyridostigmine 0.25 mg kg-1 on serum cholinesterase activity was investigated in 20 adult patients undergoing elective surgery. Both drugs produced marked depression of enzymatic activity. The maximal depression was observed in samples taken 5 min after injection. The maximal percentage depression of enzymatic activity was not significantly different in the two drug groups. However, at 30-60 min after injection, the degree of depression was less in the neostigmine group. This may be attributed to the different plasma clearances of neostigmine and pyridostigmine.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7272149     DOI: 10.1093/bja/53.8.849

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  7 in total

Review 1.  Anaesthesia and myasthenia gravis.

Authors:  A Baraka
Journal:  Can J Anaesth       Date:  1992-05       Impact factor: 5.063

2.  Technical report: exploring the basis of congenital myasthenic syndromes in an undergraduate course, using the model organism, Caenorhabditis elegans.

Authors:  Bonnie Kaas; Avinash R Vaidya; Amanda Leatherman; Stephanie Schleidt; Rebecca Eustance Kohn
Journal:  Invert Neurosci       Date:  2010-04-30

3.  The reversal of profound mivacurium-induced neuromuscular blockade.

Authors:  Y J Kao; N D Le
Journal:  Can J Anaesth       Date:  1996-11       Impact factor: 5.063

4.  Multivariate determinants of the need for postoperative ventilation in myasthenia gravis.

Authors:  M Naguib; A A el Dawlatly; M Ashour; E A Bamgboye
Journal:  Can J Anaesth       Date:  1996-10       Impact factor: 5.063

5.  Edrophonium and plasma cholinesterase activity.

Authors:  R K Mirakhur
Journal:  Can Anaesth Soc J       Date:  1986-09

6.  Succinylcholine apnoea: attempted reversal with anticholinesterases.

Authors:  D R Bevan; F Donati
Journal:  Can Anaesth Soc J       Date:  1983-09

7.  Determination of erythrocyte-bound acetylcholinesterase activity for monitoring pyridostigmine therapy in myasthenia gravis.

Authors:  T Henze; M Nenner; H C Michaelis
Journal:  J Neurol       Date:  1991-07       Impact factor: 4.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.